No admission of liability but lots of money being thrown in the direction of claimants.
Bloomberg has the latest update regarding the huge settlements GlaxoSmithKline are making with regard to the Paxil lawsuits in America. They are reporting that GSK has agreed to pay more than $1 billion to resolve more than 800 cases alleging its Paxil antidepressant caused birth defects in some users children.
Furthermore they add:
The birth-defect settlements bring to more than $2 billion the amount Glaxo has agreed to pay to resolve a variety of Paxil-related suits, including claims it caused suicides or attempted suicides and addiction problems. GlaxoSmithKline's Sarah Alspach chipped in with the obligatory...
GSK believes it acted properly and responsibly in conducting its clinical trial program, in marketing the medicine, in monitoring its safety once it was approved for use and in updating pregnancy information in the medicines label as new information became available. GlaxoSmithKline are the subject of a UK Group Action. The case goes to trial later this year.
The Seroxat Group Action claims are being pursued under the Consumer Protection Act [CPA] 1987.
The CPA provides for a non-fault based liability if the product is found to be defective and to have caused injury as a result. The Claimants allege difficulties in withdrawing from the drug.
The action is due for trial in the High Court in London later this year.
As yet, GlaxoSmithKline, have made no approach to settle this particular case despite settling with US litigants in similar withdrawal cases.
In all honesty, I would just love it if GlaxoSmithKline stood in the High Court and presented evidence that suggested there *wasn't* a problem regarding Paxil withdrawal. The items of disclosure obtained by the claimant's lawyers would then become public and I would love nothing more than to upload them for the whole world to see on here.
Last year Glaxo were ordered to pay $2.5million over claims that its Paxil antidepressant caused birth defects. Jurors in state court in Philadelphia deliberated about seven hours over two days before finding Glaxo failed to properly warn doctors and pregnant users of Paxils risk. The panel awarded $2.5 million in compensatory damages to the family of Lyam Kilker. The 3-year-old was born with heart defects his mother blamed on the drug.
Glaxo appealed the decision but have since settled.
The court transcripts from the GSK V Kilker trial can be viewed here: